The facility will operate in low Earth orbit and focus on experiments that gravity-bound labs cannot perform; the company says the lab will shorten the timeline between discovery and therapy by unlocking new biological insights
An illustration of the space lab. Pic Courtesy/Spark Microgravity
SPARK Microgravity GmbH revealed plans to build Europe’s first dedicated commercial orbital cancer laboratory.
The facility will operate in low Earth orbit and focus on experiments that gravity-bound labs cannot perform.
The company says the lab will shorten the timeline between discovery and therapy by unlocking new biological insights.
SPARK said space-based research could expose biological signals that remain hidden on Earth, as gravity affects how cells grow, settle, and interact. These constraints don’t exist in orbit.
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever
Subscribe today by clicking the link and stay updated with the latest news!" Click here!
